dc.contributor.author | Chalabianloo, Fatemeh | |
dc.contributor.author | Høiseth, Gudrun | |
dc.contributor.author | Vold, Jørn Henrik | |
dc.contributor.author | Johansson, Kjell Arne | |
dc.contributor.author | Kringen, Marianne K. | |
dc.contributor.author | Dalgard, Olav | |
dc.contributor.author | Ohldieck, Christian | |
dc.contributor.author | Druckrey-Fiskaaen, Karl Trygve | |
dc.contributor.author | Aas, Christer Frode | |
dc.contributor.author | Løberg, Else-Marie | |
dc.contributor.author | Bramness, Jørgen Gustav | |
dc.contributor.author | Fadnes, Lars T. | |
dc.date.accessioned | 2022-07-22T06:42:05Z | |
dc.date.available | 2022-07-22T06:42:05Z | |
dc.date.created | 2022-05-15T17:18:52Z | |
dc.date.issued | 2022 | |
dc.identifier.citation | Journal of Addictive Diseases. 2022, 1-12. | |
dc.identifier.issn | 1055-0887 | |
dc.identifier.uri | https://hdl.handle.net/11250/3007687 | |
dc.language.iso | eng | |
dc.title | Impact of liver fibrosis and clinical characteristics on dose-adjusted serum methadone concentrations | |
dc.title.alternative | Impact of liver fibrosis and clinical characteristics on dose-adjusted serum methadone concentrations | |
dc.type | Peer reviewed | |
dc.type | Journal article | |
dc.description.version | publishedVersion | |
dc.source.pagenumber | 1-12 | |
dc.source.journal | Journal of Addictive Diseases | |
dc.identifier.doi | 10.1080/10550887.2022.2057140 | |
dc.identifier.cristin | 2024705 | |
dc.relation.project | Helse Vest RHF: F-11328 - 912126 | |
cristin.ispublished | true | |
cristin.fulltext | original | |
cristin.qualitycode | 1 | |